A Chinese multicenter, real-world study of PD-L1 inhibitors in extensive stage small cell lung cancer

被引：0
|
作者：
Peng, J. [1 ]
Meng, R. [2 ]
Liu, X. [3 ]
Zhang, L. [4 ]
Wang, L. [5 ]
Feng, R. [1 ]
Feng, H. [6 ]
Huang, Z. [7 ]
Yao, D. [8 ]
Li, X. [9 ]
Liu, N. [10 ]
Tan, B. [11 ]
Li, S. [12 ]
Yu, J. [1 ]
Meng, X. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Radiat Oncol, Jinan, Peoples R China
[2] Huazhong Univ Sci & Technol, Canc Ctr Union Hosp, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[3] Jinzhou Med Univ, Oncol Dept, Jinzhou, Peoples R China
[4] Hunan Canc Hosp, Thorac Dept, Changsha, Peoples R China
[5] Baotou Canc Hosp, Baotou, Peoples R China
[6] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China
[7] Shandong Prov Hosp, Jinan, Peoples R China
[8] Chaoyang Second Hosp, Chaoyang, Peoples R China
[9] Chifeng Municipal Hosp, Chifeng, Inner Mongolia, Peoples R China
[10] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
[11] Shandong Univ, Qilu Hosp, Radiat Oncol, Jinan, Peoples R China
[12] Zibo Municipal Hosp, Zibo, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
172P
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [21] Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian Perspective
    Prabhakaran, S.
    Russell, P. A.
    Farrall, A. L.
    Asadi, K.
    Barrett, W.
    Cooper, C.
    Cooper, W.
    Duhig, E. E.
    Egan, M.
    Fox, S.
    Godbolt, D.
    Gupta, S.
    Cotton, S.
    Leslie, C.
    Leong, T.
    Moffat, D.
    Qiu, M.
    Sivasubramaniam, V.
    Snell, C.
    Skerman, J.
    Walsh, M.
    Whale, K.
    Klebe, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S479 - S479
  • [22] Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: A real-world study of a large Chinese cohort
    Jin, Yan
    Shen, Xuxia
    Pan, Yunjian
    Zheng, Qiang
    Chen, Haiquan
    Hu, Hong
    Li, Yuan
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : 4591 - 4601
  • [23] Brazilian real-world data of immunotherapy in extensive stage small cell lung cancer
    Duarte, Flavia A.
    Dienstmann, Rodrigo
    Diniz, Paulo H. C.
    Silva, Matheus C. e
    Veloso, Gilson G. V.
    Arcanjo, Georgia S.
    Paes, Rafael
    Montella, Tatiane C.
    Lima, Helena F. C. A.
    Ferrari, Bruno L.
    Macuzo, Eliane V.
    Ferreira, Carlos G.
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [24] Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
    Xiang, Y.
    Tang, Y.
    Luan, T.
    Mengchen, L.
    Shi, W.
    Chin, A. G. W.
    Feng, X.
    Wang, F.
    Sun, X. W.
    Bao, Z.
    Zhou, J.
    Zhao, J.
    Wu, H.
    Fu, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S1666 - S1667
  • [25] Efficacy of immunotherapy for extensive-stage small cell esophageal cancer: A multicenter real-world retrospective study
    Fan, B.
    Qiu, X.
    Wang, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S102 - S102
  • [26] The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study
    Choi, Myeong Geun
    Kim, Yeon Joo
    Lee, Jae Cheol
    Ji, Wonjun
    Oh, In -Jae
    Lee, Sung Yong
    Yoon, Seong Noon
    Lee, Shin Yup
    Lee, Jeong Eun
    Kim, Eun Young
    Choi, Chang-Min
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 422 - 429
  • [27] Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancerA retrospective Austrian multicenter study
    Sabine Geiger-Gritsch
    Horst Olschewski
    Florian Kocher
    Robert Wurm
    Gudrun Absenger
    Martin Flicker
    André Hermann
    Peter Heininger
    Michael Fiegl
    Melanie Zechmeister
    Florian Endel
    Claudia Wild
    Georg Pall
    Wiener klinische Wochenschrift, 2021, 133 : 1122 - 1130
  • [28] Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
    Peng Song
    Jingcheng Zhang
    Congcong Shang
    Li Zhang
    Scientific Reports, 10
  • [29] A real-world study of PD-L1 testing patterns and PD-1/PD-L1 inhibitor therapy in patients with metastatic non-small cell lung cancer: An analysis of the Sotiria Hospital lung cancer registry
    Charpidou, Andriani
    Syrigos, Nikolaos K.
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Tsagouli, Sofia
    Burke, Thomas
    Spanoudi, Filio
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Gkiozos, Ioannis
    PNEUMON, 2024,
  • [30] Real-world utilization of immune checkpoint inhibitors in extensive stage small-cell lung cancer in community settings
    Zu, Ke
    Arunachalam, Ashwini
    Hohlbauch, Andriana
    Silver, Michelle
    Robert, Nicholas
    IMMUNOTHERAPY, 2023, 15 (16) : 1375 - 1387
12345